Minimum requirements for bluetongue virus primary replication in vivo.

scientific article published on 31 October 2012

Minimum requirements for bluetongue virus primary replication in vivo. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JVI.02363-12
P932PMC publication ID3554043
P698PubMed publication ID23115294

P50authorPolly RoyQ20054092
P2093author name stringEiko Matsuo
P2860cites workA reverse genetics system of African horse sickness virus reveals existence of primary replication.Q39225705
Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimeric virus formationQ39225711
Phosphorylation of bluetongue virus nonstructural protein 2 is essential for formation of viral inclusion bodies.Q39257481
Reconstitution of bluetongue virus polymerase activity from isolated domains based on a three-dimensional structural model.Q39583968
Nonstructural protein 3 of bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101.Q39598340
Functional dissection of the major structural protein of bluetongue virus: identification of key residues within VP7 essential for capsid assemblyQ39612372
Defining the structure-function relationships of bluetongue virus helicase protein VP6.Q40012095
Bluetongue virus tubules made in insect cells by recombinant baculoviruses: expression of the NS1 gene of bluetongue virus serotype 10.Q40130755
Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirusQ40339214
Orbivirus structure and assemblyQ40978507
Interactions between the inner and outer capsids of bluetongue virusQ41039228
Structure of a hexameric RNA packaging motor in a viral polymerase complex.Q41625360
The serine protease domain of hepatitis C viral NS3 activates RNA helicase activity by promoting the binding of RNA substrateQ43041225
Role of the histidine triad-like motif in nucleotide hydrolysis by the rotavirus RNA-packaging protein NSP2.Q44709125
Systemic immune response after rotavirus inoculation of neonatal mice depends on source and level of purification of the virus: implications for the use of heterologous vaccine candidatesQ45407914
Studies on the in vitro and the in vivo transcription of the bluetongue virus genomeQ45819593
Purification and characterization of bluetongue virusQ45823198
Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotypes 1 and 4.Q45835195
Uncoating of parental bluetongue virus to core and subcore particles in infected L cellsQ45835212
In vitro transcription and translation of bluetongue virus mRNA.Q45841785
RNA packaging device of double-stranded RNA bacteriophages, possibly as simple as hexamer of P4 protein.Q45935314
Functional visualization of viral molecular motor by hydrogen-deuterium exchange reveals transient statesQ46440751
Interaction of packaging motor with the polymerase complex of dsRNA bacteriophage.Q54466205
Characterization of the Nucleoside Triphosphate Phosphohydrolase and Helicase Activities of the Reovirus λ1 ProteinQ73500689
The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus releaseQ24538680
Bluetongue virus RNA binding protein NS2 is a modulator of viral replication and assemblyQ27478024
Bluetongue virus: dissection of the polymerase complexQ27489424
Bluetongue virus VP4 is an RNA-capping assembly lineQ27644374
The atomic structure of the bluetongue virus coreQ27765694
The protein family of RNA helicasesQ28283208
Identification and characterization of the helix-destabilizing activity of rotavirus nonstructural protein NSP2.Q33840273
Bluetongue virus VP1 polymerase activity in vitro: template dependency, dinucleotide priming and cap dependencyQ34081742
Identification and characterization of a novel non-structural protein of bluetongue virusQ34126290
Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release.Q34186230
Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challengeQ34204054
Functional mapping of bluetongue virus proteins and their interactions with host proteins during virus replicationQ34755412
In vitro reconstitution of Bluetongue virus infectious cores.Q35170961
Bluetongue virus non-structural protein 1 is a positive regulator of viral protein synthesisQ36341193
Capping and methylation of mRNA by purified recombinant VP4 protein of bluetongue virus.Q36792917
Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV.Q36803290
Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts.Q36845821
Bluetongue virus VP6 protein binds ATP and exhibits an RNA-dependent ATPase function and a helicase activity that catalyze the unwinding of double-stranded RNA substrates.Q38342902
Interaction between Bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egressQ38907886
Recovery of infectious bluetongue virus from RNA.Q38918571
Purified recombinant bluetongue virus VP1 exhibits RNA replicase activityQ38918573
Interaction of calpactin light chain (S100A10/p11) and a viral NS protein is essential for intracellular trafficking of nonenveloped bluetongue virusQ38935560
A viral nonstructural protein regulates bluetongue virus trafficking and releaseQ38935564
Specific binding of Bluetongue virus NS2 to different viral plus-strand RNAs.Q39195959
Sequence specificity in the interaction of Bluetongue virus non-structural protein 2 (NS2) with viral RNA.Q39195962
P4510describes a project that usesImageJQ1659584
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectbluetongue virusQ883122
P304page(s)882-889
P577publication date2012-10-31
P1433published inJournal of VirologyQ1251128
P1476titleMinimum requirements for bluetongue virus primary replication in vivo
P478volume87

Reverse relations

cites work (P2860)
Q38945292Analysis of murine B-cell epitopes on bluetongue virus 12 nonstructural protein 1.
Q37174442Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes
Q38246708Bluetongue virus capsid assembly and maturation.
Q59359646CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR Mice
Q39259973Cellular Casein Kinase 2 and Protein Phosphatase 2A Modulate Replication Site Assembly of Bluetongue Virus.
Q41637897Detection, discrimination and quantitation of 22 bluetongue virus serotypes using real-time RT-PCR with TaqMan MGB probes
Q35756880Development of reverse genetics for Ibaraki virus to produce viable VP6-tagged IBAV.
Q57291702Dynamic network approach for the modelling of genomic sub-complexes in multi-segmented viruses
Q38832246Establishment of an entirely plasmid-based reverse genetics system for Bluetongue virus
Q38744368Establishment of different plasmid only-based reverse genetics systems for the recovery of African horse sickness virus
Q42003156Factors that affect the intracellular localization and trafficking of African horse sickness virus core protein, VP7.
Q37687263Generation of infectious RNA complexes in Orbiviruses: RNA-RNA interactions of genomic segments.
Q54232991Generation of recombinant rotaviruses expressing fluorescent proteins using an optimized reverse genetics system.
Q35888832Identification of four novel group-specific bluetongue virus NS3 protein B-cell epitopes
Q35927349Identification of the Genome Segments of Bluetongue Virus Serotype 26 (Isolate KUW2010/02) that Restrict Replication in a Culicoides sonorensis Cell Line (KC Cells).
Q42249133In silico prediction and in vitro identification of bluetongue virus 4 VP5 protein B-cell epitopes
Q35676008Influence of cellular trafficking pathway on bluetongue virus infection in ovine cells
Q45324799Interaction between a unique minor protein and a major capsid protein of Bluetongue virus controls virus infectivity
Q91728852PCR-based reverse genetics strategy for bluetongue virus recovery
Q91872284Prospects of Next-Generation Vaccines for Bluetongue
Q35128134RNA elements in open reading frames of the bluetongue virus genome are essential for virus replication
Q37123514Rapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheep
Q40628405Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV).
Q34711935Sequential packaging of RNA genomic segments during the assembly of Bluetongue virus.
Q39225680Structure based modification of Bluetongue virus helicase protein VP6 to produce a viable VP6-truncated BTV.
Q64266203The Interaction of Bluetongue Virus VP6 and Genomic RNA Is Essential for Genome Packaging
Q38152158The immune response of ruminant livestock to bluetongue virus: from type I interferon to antibody
Q38174017The molecular biology of Bluetongue virus replication
Q30603531Trafficking of bluetongue virus visualized by recovery of tetracysteine-tagged virion particles.

Search more.